Literature DB >> 9070664

Binding and transport of melanoma-specific antigenic peptides by the transporter associated with antigen processing.

S A Chang1, V G Lacaille, D S Guttoh, M J Androlewicz.   

Abstract

To gain insight into how tumor antigens are generated and presented, a panel of peptides corresponding to melanoma-specific T cell epitopes were tested for their transport capacity by the transporter associated with antigen processing (TAP). The melanoma epitopes exhibited differential capacities to be transported by TAP in streptolysin O-permeabilized cells, as well as differential competition for peptide binding to TAP. The data indicate that some melanoma-specific epitopes are good substrates for TAP, while others are poor substrates for TAP. One of the epitopes, derived from tyrosinase, was transported into the endoplasmic reticulum (ER), in spite of being a poor competitor for reporter peptide transport and for peptide binding. These results suggest that the melanoma antigens follow distinct pathways for presentation, along the MHC class I pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9070664     DOI: 10.1016/s0161-5890(96)00082-x

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  2 in total

Review 1.  Specific immunotherapy of cancer in elderly patients.

Authors:  S Matzku; M Zöller
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Archaeosome adjuvant overcomes tolerance to tumor-associated melanoma antigens inducing protective CD8 T cell responses.

Authors:  Lakshmi Krishnan; Lise Deschatelets; Felicity C Stark; Komal Gurnani; G Dennis Sprott
Journal:  Clin Dev Immunol       Date:  2011-01-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.